Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Dec 3, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 138
- −10 vs. Q2 2021
- Portfolio value
- $6.86B
- −$827.2M (−10.8%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,387,745 | $599.3M | 8.7% | +201,847+6.3% | Added | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $454.8M | 6.6% | – | – | – |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $363.6M | 5.3% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $307.7M | 4.5% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,489,772 | $283.3M | 4.1% | +530,000+4.8% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 26,559,443 | $253.6M | 3.7% | +3,438,114+14.9% | Added | History |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $217.1M | 3.2% | 00.0% | Unchanged | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,956,940 | $214.4M | 3.1% | −28,062−1.4% | Reduced | History |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $180.3M | 2.6% | – | – | – |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $171.2M | 2.5% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,086,727 | $150.1M | 2.2% | +443,632+9.6% | Added | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $126.2M | 1.8% | – | – | – |
| ISEEIVERIC bio, Inc. | COM | 7,471,798 | $121.3M | 1.8% | +2,886,286+62.9% | Added | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 4,407,399 | $112.3M | 1.6% | +254,710+6.1% | Added | History |
| NVTAInvitae Corp | COM | 3,923,741 | $111.6M | 1.6% | −895,060−18.6% | Reduced | History |
| ZYMEZymeworks Inc. | COM | 3,679,845 | $106.9M | 1.6% | −625,755−14.5% | Reduced | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 2,258,566 | $100.9M | 1.5% | 00.0% | Unchanged | History |
| OMOutset Medical, Inc. | COM | 1,990,633 | $98.4M | 1.4% | −396,902−16.6% | Reduced | History |
| MGTXMeiraGTx Holdings plc | COM | 6,948,277 | $91.6M | 1.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,907,565 | $90.3M | 1.3% | +431,905+17.4% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,903,879 | $87.0M | 1.3% | 00.0% | Unchanged | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,963,517 | $83.4M | 1.2% | 00.0% | Unchanged | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 2,259,224 | $79.2M | 1.2% | 00.0% | Unchanged | History |
| RXDXPrometheus Biosciences, Inc. | COM | 3,314,032 | $78.6M | 1.1% | 00.0% | Unchanged | History |
| CHRSCoherus Oncology, Inc. | COM | 4,779,387 | $76.8M | 1.1% | +81,775+1.7% | Added | History |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $73.6M | 1.1% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,310,261 | $69.1M | 1.0% | −441,342−16.0% | Reduced | History |
| PRCTPROCEPT BioRobotics Corp | COM | 1,656,990 | $63.2M | 0.9% | +1,656,990 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $61.3M | 0.9% | −75,000−3.7% | Reduced | History |
| ICVXIcosavax, Inc. | COM | 1,922,549 | $56.9M | 0.8% | +1,922,549 | New | History |
| NAUTNautilus Biotechnology, Inc. | COM | 8,911,151 | $54.7M | 0.8% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,421,142 | $50.7M | 0.7% | −106,910−4.2% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 887,340 | $50.3M | 0.7% | −50,800−5.4% | Reduced | History |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $49.4M | 0.7% | – | – | – |
| TVTXTravere Therapeutics, Inc. | COM | 1,965,555 | $47.7M | 0.7% | +120,000+6.5% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $46.8M | 0.7% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 483,007 | $46.3M | 0.7% | −328,825−40.5% | Reduced | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 3,610,412 | $45.1M | 0.7% | 00.0% | Unchanged | History |
| MGNXMacrogenics Inc | COM | 2,148,060 | $45.0M | 0.7% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 461,248 | $44.3M | 0.6% | +175,207+61.3% | Added | History |
| ATNXAthenex, Inc. | COM | 13,532,467 | $40.7M | 0.6% | 00.0% | Unchanged | History |
| VERUVeru Inc. | COM | 4,451,342 | $38.0M | 0.6% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 2,537,019 | $38.0M | 0.6% | 00.0% | Unchanged | – |
| QTNTQuotient Ltd | SHS | 16,200,818 | $37.9M | 0.6% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $37.7M | 0.5% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 1,121,490 | $37.4M | 0.5% | +214,400+23.6% | Added | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 505,541 | $36.2M | 0.5% | −194,867−27.8% | Reduced | History |
| OMICSingular Genomics Systems, Inc. | COM | 3,073,824 | $34.4M | 0.5% | −9,046−0.3% | Reduced | History |
| CYPHCypherpunk Technologies Inc. | COM | 8,476,496 | $34.0M | 0.5% | 00.0% | Unchanged | History |
| TMCITreace Medical Concepts, Inc. | COM | 1,235,886 | $33.2M | 0.5% | 00.0% | Unchanged | History |
| CMAXCareMax, Inc. | COM CL A | 3,385,000 | $32.7M | 0.5% | +65,000+2.0% | Added | History |
| IMTXImmatics N.V. | SHS | 2,500,000 | $32.5M | 0.5% | 00.0% | Unchanged | History |
| LONALeonaBio, Inc. | COM | 3,425,916 | $32.1M | 0.5% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $32.1M | 0.5% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 2,022,051 | $30.9M | 0.5% | +343,078+20.4% | Added | History |
| NVRONevro Corp | COM | 259,972 | $30.3M | 0.4% | −558,788−68.2% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 3,041,004 | $30.2M | 0.4% | 00.0% | Unchanged | History |
| HCATHealth Catalyst, Inc. | COM | 589,004 | $29.5M | 0.4% | +22,920+4.0% | Added | History |
| LYRALyra Therapeutics, Inc. | COM | 3,222,560 | $29.4M | 0.4% | 00.0% | Unchanged | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $27.9M | 0.4% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 3,188,750 | $26.8M | 0.4% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 141,700 | $26.2M | 0.4% | −475,102−77.0% | Reduced | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 2,050,000 | $25.4M | 0.4% | +2,050,000 | New | History |
| BCABBioAtla, Inc. | COM | 850,026 | $25.0M | 0.4% | +164,507+24.0% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,423,000 | $23.4M | 0.3% | +628,494+79.1% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 885,818 | $21.8M | 0.3% | −193,210−17.9% | Reduced | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 393,613 | $21.3M | 0.3% | −349,086−47.0% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 615,000 | $20.3M | 0.3% | −46,162−7.0% | Reduced | History |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 2,500,000 | $19.0M | 0.3% | +2,500,000 | New | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 491,332 | $18.8M | 0.3% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 1,580,607 | $18.7M | 0.3% | +1,580,607 | New | History |
| IMRXImmuneering Corp | CLASS A COM | 681,051 | $18.1M | 0.3% | +681,051 | New | History |
| NTRANatera, Inc. | COM | 160,000 | $17.8M | 0.3% | +160,000 | New | History |
| TYRATyra Biosciences, Inc. | COM | 987,500 | $17.4M | 0.3% | +987,500 | New | History |
| ATXSAstria Therapeutics, Inc. | COM | 1,959,652 | $17.3M | 0.3% | +1,959,652 | New | History |
| ABSIAbsci Corp | COM | 1,476,776 | $17.2M | 0.3% | +1,476,776 | New | History |
| NUVLNuvalent, Inc. | COM | 750,000 | $16.9M | 0.2% | +750,000 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,888,889 | $15.8M | 0.2% | 00.0% | Unchanged | History |
| AGRXAgile Therapeutics Inc | COM | 15,919,925 | $15.3M | 0.2% | 00.0% | Unchanged | History |
| ADMAAdma Biologics, Inc. | COM | 13,262,375 | $15.0M | 0.2% | −3,322,427−20.0% | Reduced | History |
| HYPRHyperfine, Inc. | CL A SHS | 1,500,000 | $14.8M | 0.2% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 400,000 | $14.8M | 0.2% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 875,093 | $14.3M | 0.2% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 781,236 | $14.1M | 0.2% | −68,764−8.1% | Reduced | History |
| BIIBBiogen Inc. | COM | 48,600 | $13.8M | 0.2% | +48,600 | New | History |
| VTRSViatris Inc | Stock | 1,004,419 | $13.6M | 0.2% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 556,047 | $13.2M | 0.2% | −200,000−26.5% | Reduced | History |
| CM Life Sciences III Inc125841205 | UNIT 04/30/2028 | 1,250,000 | $12.8M | 0.2% | 00.0% | Unchanged | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $12.8M | 0.2% | – | – | – |
| PODDInsulet Corp | Stock | 44,522 | $12.7M | 0.2% | +44,522 | New | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $12.0M | 0.2% | 00.0% | Unchanged | History |
| ADPTAdaptive Biotechnologies Corp | COM | 352,804 | $12.0M | 0.2% | 00.0% | Unchanged | History |
| ACCDAccolade, Inc. | COM | 279,774 | $11.8M | 0.2% | +34,033+13.8% | Added | History |
| ZYZymergen Inc. | COM | 883,332 | $11.6M | 0.2% | −750,000−45.9% | Reduced | History |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $11.1M | 0.2% | 00.0% | Unchanged | History |
| ONEM1Life Healthcare Inc | COM | 532,350 | $10.8M | 0.2% | +16,306+3.2% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 180,000 | $10.6M | 0.2% | +180,000 | New | History |
| ONCROncorus, Inc. | COM | 1,099,810 | $10.3M | 0.1% | −363,789−24.9% | Reduced | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 375,256 | $10.1M | 0.1% | 00.0% | Unchanged | History |
| Summit Healthcre Acquistn CoG8566R128 | UNIT 06/03/2026 | 1,000,000 | $10.1M | 0.1% | 00.0% | Unchanged | – |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ChemoCentryx, Inc.16383L106 | COM | – | $15.8M |
| FLNAFilana Therapeutics, Inc. | COM | $6.21M | – |
Sold out since Q2 2021 (34)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $60.8M | 0.8% | History |
| MDTMedtronic plc | Stock | 450,000 | $55.9M | 0.7% | History |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $29.9M | 0.4% | History |
| EXASExact Sciences Corp | COM | 233,523 | $29.0M | 0.4% | History |
| NARIInari Medical, Inc. | Stock | 310,437 | $29.0M | 0.4% | History |
| XLRNAcceleron Pharma Inc | COM | 226,760 | $28.5M | 0.4% | History |
| RGENRepligen Corp | COM | 132,500 | $26.4M | 0.3% | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 315,141 | $26.1M | 0.3% | History |
| COLLCollegium Pharmaceutical, Inc | COM | 978,277 | $23.1M | 0.3% | History |
| FBRXForte Biosciences, Inc. | COM | 685,000 | $23.0M | 0.3% | History |
| STOKStoke Therapeutics, Inc. | COM | 671,978 | $22.6M | 0.3% | History |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 1,250,000 | $16.8M | 0.2% | – |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 7,687,185 | $16.2M | 0.2% | – |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,500,000 | $15.4M | 0.2% | – |
| CVRXCVRx, Inc. | COM | 440,000 | $12.3M | 0.2% | History |
| CTMXCytomX Therapeutics, Inc. | COM | 1,640,957 | $10.4M | 0.1% | History |
| SILKSilk Road Medical Inc | COM | 147,133 | $7.04M | 0.1% | History |
| PRVAPrivia Health Group, Inc. | COM | 135,000 | $5.99M | 0.1% | History |
| AKYAAkoya Biosciences, Inc. | COM | 300,000 | $5.80M | 0.1% | History |
| BCTG Acquisition Corp05492W103 | COM | 500,000 | $5.69M | 0.1% | – |
| MREOMereo BioPharma Group plc | SPON ADS | 1,696,068 | $5.38M | 0.1% | History |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 500,000 | $5.20M | 0.1% | – |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 500,000 | $5.04M | 0.1% | – |
| MRUSMerus N.V. | COM | 175,000 | $3.69M | <0.1% | History |
| AMWLAmerican Well Corp | CL A | 290,000 | $3.65M | <0.1% | History |
| CM Life Sciences Inc18978W109 | COM CL A | 227,000 | $3.18M | <0.1% | – |
| GRTXGalera Therapeutics, Inc. | COM | 254,664 | $2.50M | <0.1% | History |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 133,066 | $1.91M | <0.1% | – |
| SGTXSigilon Therapeutics, Inc. | COM | 125,000 | $1.34M | <0.1% | History |
| SRRASierra Oncology, Inc. | COM NEW | 66,655 | $1.30M | <0.1% | History |
| SC Health CorpG78516401 | *W EXP 99/99/999 | 500,000 | $1.05M | <0.1% | – |
| PLXPPLx Pharma Winddown Corp. | COM | 57,459 | $793.0K | <0.1% | History |
| TKNOAlpha Teknova, Inc. | COM | 30,000 | $712.0K | <0.1% | History |
| TCRRTCR2 Therapeutics Inc. | COM | 30,753 | $505.0K | <0.1% | History |